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Abstract
Background: To describe the organization of an ECMO-centre from triage by telephone to the phase of inter-
hospital transportation with ECMO of patients affected by H1N1-induced ARDS, describing techniques and
equipment used.
Methods: From September 2009 to January 2010, 18 patients with H1N1-induced ARDS were referred to our
ECMO-centre from other hospitals. Six patients had contraindications to treatment with ECMO and remained in the
local hospital. Twelve patients were transported to our centre and were included in this study. Four patients were
transported on ECMO (Group A) and eight on conventional ventilation (Group B). The groups were compared on
the basis of adverse events during transport, clinical characteristics and outcome.
Results: The PaO2/FiO2 ratio was lower in the patients of Group A (46.8 vs 89.7 [median]) despite the PEEP values
being higher (15.0 vs 8.5 [median]). The Murray score was higher in Group A (3.50 vs 2.75 [median]). During the
transfer there were no significant complications noted in Group A, whereas two patients in Group B were reported
with hypoxia (SpO2 < 90%). One patient in Group A died. All the other patients of the two groups have been
discharged from hospital.
Conclusions: The creation of an ECMO team, with various experts in the treatment of ARDS, assured a safe transfer
of patients with severe hypoxia, over long distances, when in other cases they wouldn’t have been be
transportable.
Background
Extra-corporeal membrane oxygenation (ECMO) is gen-
erally used in the treatment of patients with extremely
severe but potentially reversible pulmonary disorders
[1,2]. The new influenza A(H1N1) pandemic affected
Italy during the 2009 winter. It caused an epidemic of
critical illness with a large number of patients admitted
to the intensive care unit (ICU) [3,4]. A proportion of
these patients presented or developed severe acute
respiratory distress syndrome (ARDS)[5,6]. Several
reports described the need of ECMO for treatment of
refractory hypoxaemia, hypercapnia which occurred
despite mechanical ventilation and rescue ARDS therapy
[1,2]. The patients should ideally be transported to an
ECMO centre before respiration becomes critically
unstable as it is thereafter impossible to transport them
by conventional means. In some severely ill patients, it
is sometimes necessary to initiate ECMO at the local
hospital and, thereafter, to transport the patient back to
the ECMO centre. This report describes the organiza-
tion of an ECMO-centre in central Italy, from triage by
telephone to the phase of inter-hospital transportation
with ECMO, describing techniques and equipment used.
We also compared the safety of transport and the
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outcome of patients with H1N1-related ARDS on
ECMO, transferred from peripheral hospitals, with
patients who were transferred to our centre by conven-
tional means.
Methods
The Italian Ministry of Health identified 11 ECMO cen-
tres to which critically ill patients with H1N1-induced
respiratory failure could be transferred, thereafter it
developed criteria for the evaluation of ECMO need in
patients admitted to peripheral hospitals. Following the
Italian Ministry of Health dispositions, the Intensive
Care Unit (ICU) of the Emergency Department of a ter-
tiary trauma centre (Careggi Teaching Hospital, Flor-
ence, Italy) became one of the referral centres for
Central Italy for H1N1-induced ARDS. Up to 31 January
2010 the H1N1 cases requiring respiratory support in
Italy were 443, and twelve (2.7%) were treated in our
ECMO Centre [7].
Table 1 summarizes criteria following Ministerial
Guidelines, for ECMO-need evaluation in patients
admitted to peripheral hospitals. From September 2009
to January 2010 our ECMO-centre received reports of
18 patients with H1N1-induced ARDS from other hos-
pitals. Six patients had contraindications to treatment
with ECMO and remained in the local hospital: three
patients were terminally ill with a short life expectancy,
two patients with advanced and prolonged multiple
organ dysfunction, one patient with severe chronic lung
disease. Twelve patients were transported to our centre
and were included in this study. Four patients were
transported on ECMO and eight with conventional
transport. The patients were divided into 2 groups
(Group A: 4 patients transferred on ECMO; Group B: 8
patients transferred with conventional transport). All
patients included in this study had an H1N1 infection
confirmed by real-time reverse transcriptase-polymer-
ase-chain-reaction (RT-PCR) assayed on pharyngeal
swab or bronchial lavage. Not included were the patients
with clinical suspicion of H1N1 infection without RT-
PCR confirmation. Informed consent was obtained from
patients or their relatives. This study, supported by insti-
tutional funds only, followed the principles of the Hel-
sinki declaration and was approved by the Internal
Review Board.
Organization of the ECMO-Centre
The ECMO service was activated by phone call from the
peripheral hospital, and the intensivist on duty sub-
mitted a questionnaire to evaluate the indication for
ECMO treatment. When possible, the patient was trans-
ferred by conventional transport to the ECMO Centre.
If the clinical condition was unstable and/or the local
hospital too far to assure safe transport, the ECMO-
team was activated. The ECMO-team was activated in
the presence of this condition: PaO2/FiO2 < 70 or
PaCO2 > 55 mmHg. The parameter refers to a condi-
tion of protective lung ventilation (tidal volume:4-6 ml/
Kg of predicted body weight; plateau pressure ≤ 30
cmH20; PEEP > lower inflection point of the pressure-
volume curve). The internal activation system counted
on the possibility to recruit all the professional figures
involved in ECMO-team in less than one hour. The
health personnel involved were: intensivist, cardiac sur-
geon, cardiologist, perfusionist and nurses. All these fig-
ures had previously been trained in ECMO technique
and management.
Equipment and transport
An ambulance and a medical car were used for the
transport of medical staff and the equipment. The
ambulance was planned for this use, it has internal
spaces and adapted support for the attachment of the
ECMO and the electro-medical equipment in order to
guarantee a safe transportation. A mobile structure had
been developed for the transport of all ECMO compo-
nents: circuit tubing, rotaflow pump, membrane oxyge-
nator and oxygen tank. The structure was carried by
hand without a cart and could be safely fixed to a sup-
port of the ambulance. The ECLS device was a rotaflow
Table 1 Contact criteria to discuss the need of ECMO
Acute respiratory failure with 1 of the following condition:
1. SaO2 < 85% for at least 1 hour
2. Oxygenation Index >25 for at least 6 hours after ventilation’s optimisation
3. PaO2/FiO2 < 100 with PEEP ≥ 10cmH2O for at least 6 hours after ventilation’s optimization
4. Hypercapnia with pH < 7.25
5. SvO2 < 65% with hematocrit > 30 and under vasoactive drugs infusion
The Italian Ministry of Health dispositions for first contact criteria to discuss the need of ECMO in patients admitted to peripheral hospitals.
The parameter are referred to a condition of lung protective ventilation’s (tidal volume:4-6 ml/Kg of predicted body weight; plateau pressure ≤ 30 cmH20; PEEP
>lower inflection point of the curve pressure-volume).
PEEP: positive end-expiratory pressure; PaO2: arterial oxygen partial pressure; FiO2: inspired oxygen fraction; RR: respiratory rate; SaO2: peripheral oxygen
saturation; Oxygenation Index: Mean airway pressure (cmH2O) * FiO2 * 100/PaO2; SvO2: central venous oxygen saturation.
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Maquet Centrifugal Pump (Maquet, Rastatt, Germany)
connected in series to a hollow fibre membrane oxyge-
nator (Quadrox-D Oxygenator, Maquet, Rastatt, Ger-
many) and biocoated circuits. Additional equipment
components were a mechanical ventilator (Dräger Oxy-
log® 3000), multiparametric monitor (Dräger Infinity®
Delta XL), defibrillator (Medtronic LIFEPAK® 12), oxy-
gen tanks and three portable boxes containing material
for cannulation.
Bedside clinical evaluation
The decision to use the device was preceded by a thor-
ough clinical assessment of the patient which included:
compiling their past and recent medical history; viewing
X-rays or CT (if any); determining a pressure-volume
static curve with the measurement of upper and lower
inflection points; lung recruitment manoeuvres; lung
ultrasound examination; evaluation of cardiac function
and the measurement of pulmonary pressure with trans-
thoracic and trans-oesophageal echocardiography, if
MPAP was > 45 mmHg we inserted a pulmonary artery
catheter to monitor the pulmonary pressure.
According to our internal protocol, if there was inclu-
sion criteria, ECMO was begun at the local hospital.
Patient care
Prior to placement of the cannulae, vascular ultrasound
examination was performed to assess the calibre and
patency of the jugular and femoral vein. Cannulae were
positioned percutaneously. The Seldinger technique was
used and the wire was placed with vein visualization by
real-time echography. The skin and fascia would be
thoroughly dilated after the wire was placed. The cannu-
lae were Maquet Cannulae (21-28 French, Maquet, Ras-
tatt, Germany). The blood was drained from the right
atrium through a cannula introduced via femoral vein
and was returned to the jugular vein. A recent acquisi-
tion was the Avalon Elite™ Bi-Caval Dual Lumen
Catheter (DLC): a single cannula allowed simultaneous
venous drainage and re-infusion of blood via the inter-
nal jugular vein. Cannulae positioning was controlled by
real-time TEE performed by a cardiologist. We used a
continuous infusion of Eparin for systemic anticoagula-
tion. Heparinization was controlled by bedside activated
partial thromboplastin time (aPTT) with Hemocron
(Hemochron Jr. Sign. plus, ITC Europe, Milan, IT) every
two hours during transport. High flow technique (4-6
litres per minute) was adopted according to clinical con-
ditions and cardiac output. The desired temperature was
maintained by a heat-exchanger, which was connected
to the oxygenator. Blood flow and fresh gas flow were
usually delivered at 1:1 ratio. Ventilation was regulated
on protective parameters to maintain plateau pressure
lower than 25 cmH20, tidal volume equal to 4 ml per
Kg of predicted body weight and the inspired oxygen
fraction, lower than 0.5. PEEP, was established at 2
cmH2O above the lower inflection point. Chest X-ray
was performed prior to transfer to confirm the correct
positioning of the cannulae and to exclude the possibi-
lity of a pneumothorax. When the haemodynamics and
respiratory parameters stabilized, the transport to the
ECMO Centre was activated. During transport the fol-
lowing parameters were monitored: heart rate, invasive
arterial pressure, pulmonary artery pressure, peak air-
ways pressure, peripheral oxygen saturation, flow and
rpm of ECMO and PTT every two hours. The staff
wore full protective garments (including FFP3 respira-
tors, 3M Italia SpA, Segrate, Italy)
Statistical analysis
The continuous variables are reported as medians and
range.
Results
Table 2 summarizes the clinical characteristics of
patients at the moment of ECMO-centre activation and
transport characteristics. The average distance from the
local hospital to the ECMO-centre was similar in both
the groups (78 km and 80 km (median)). All the ECMO
transportation were carried out by ambulance, the con-
ventional transport included two aeroplanes and one
helicopter transfer. The ECMO-team were ready to act
165 minutes (on average) after the call and the transfer
of the patient on ECMO lasted 125 minutes (on aver-
age); during the transfer no significant complications
were noted. Hypoxia was reported in two patients of
Group B during the transfer. The PaO2/FiO2 ratio was
lower in the patients in Group A (46.8 vs 89.7(median))
despite the PEEP values being higher (15 vs 8.5 (med-
ian)). The Murray score was higher in group A (3.50 vs
2.75 (median). Table 3 contains the clinical data of the
patients during their hospitalisation in the ECMO-cen-
tre, and their outcome. Three patients in Group B were
treated with ECMO in our centre, two within the first
24 hours of hospitalisation and one after seven days.
The duration of ECMO support was similar in two
groups. In 5 patients treated with ECMO in our ICU we
noted bleeding at the entry of cannulisation and from
the airway but neither were fatal. Fifty-four percent of
the patients contracted another infection during hospita-
lisation; 5 out of 7 patients treated with ECMO con-
tracted a bacterial or fungal infection during their ICU
stay. In 2 patients legionella were present in BAL cul-
tures at the time of ICU admission, therefore the viral
infection was probably a secondary infection. The other
secondary infections caused by opportunistic germs
were most likely the expression of VAP after an
extended period of mechanical ventilation and were not
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related to transport. The duration of mechanical ventila-
tion was 14.5 days in Group A compared to 10.5 days in
Group B (median). The ICU-LOS was similar in the two
groups (16 vs 13.5 (median)). The hospital LOS in the
two groups did not differ. A patient in group B had a
very long hospitalisation (hospital LOS = 107 days)
owing to the presence of pleural empyema requiring
several surgical operations. One patient in Group A
died. The death occurred from intractable respiratory
failure due to Aspergillus infection. All the other
patients of the two groups were discharged from
hospital.
Discussion
Influenza A, H1N1 infection, can induce severe ARDS
and cases of conventional ventilation failure have been
reported; the transfer of these patients to specialized
ARDS centres is often necessary permitting advanced
treatment when ECMO is necessary. Occasionally, if the
clinical case was particularly unstable and the transfer of
this patient was risky using conventional transport, it
was necessary to start the ECMO treatment in the local
hospital and continue ECMO during the transfer. The
use of a check-list during the telephone interview
enabled the identification of patients treatable whose
conditions were more serious, and the ECMO team was
activated only for a third of the cases. In the remaining
cases the transfer of the patient to the ECMO centre
was carried out with conventional means.
Two patients experienced hypoxia during the transfer
using conventional ventilation with SpO2 < 90%; this
was because H1N1-induced ARDS evolves rapidly and
there is often a decline in oxygenation of the blood in
few hours. This was shown by the fact that the patients
had been ventilated only for a few days before the call
to our centre and three of the patients transported in
the traditional manner were treated with ECMO in our
centre, two within 24 hours of arrival, one after seven
days. The Group A patients’ conditions were, on aver-
age, more serious than Group B patients at the moment
of evaluation in terms of PaO2, PaCO2 and PEEP; per-
haps because they had previously been ventilated for a
Table 2 Clinical characteristics of patients in peripheral hospital
GROUP A (N patients:4) GROUP B (N patients:8)
Median Range Median Range
Age (years) 44.5 30-48 43.5 15-53
BMI 36.35 24.5-56.2 27.3 19.6-27.3
Distance from the local hospital to the ECMO-centre (Km) 78 35-520 80 25-740
Transfer time (minutes) 125 25-240 40 15-240
Duration of MV (days) 2.5 1-6 1 1-3
SAPS II score 42 38-54 28 24-66
SOFA score 13.5 11-16 11 4-16
ICU LOS (days) 3 1-4 1.5 2-7
Hospital LOS (days) 3.5 1-4 2 2-7
PaO2/FiO2 46.8 45.6-54.9 89.7 66.0-116.0
PaCo2 (mmHg) 63.9 54.0-89.0 49.7 21.0-63.8
PH 7.26 7.22-7.32 7.35 7.18-7.48
Peep (cm H2O) 15 10-16 8.5 6.0-10.0
Murray score 3.50 3.25-4.00 2.75 2.25-3.00
Cst (ml/cm H2O) 29.5 13.0-40.0 37 26-58
Clinical characteristics, gas exchange of patients in peripheral hospital at the moment of ECMO-centre activation and transport characteristics. All patients were at
fractional inspired concentration of oxygen (FiO2) = 1.0. PEEP: positive end-expiratory pressure; PaO2: arterial oxygen partial pressure; PaCO2: arterial carbon
dioxide partial pressure; LOS: length of stay; MV: mechanical ventilation; BMI: body mass index; SAPS: Simplified Acute Physiology Score; SOFA: Sequential Organ
Failure Assessment; Cst: static pulmonary compliance.
Table 3 Clinical data in the ECMO-center and outcome
GROUP A
(N patients:4)
GROUP B
(N patients:8)
Median Range Median Range
Duration of ECMO (days) 9.5 8-28 8 0-19
Duration of MV (days) 14.5 12-35 10.5 4-48
ICU LOS (days) 16 14-35 13.5 4-81
ICU LOS-T(days) 19 15-38 15 8-87
Hospital LOS-T (days) 39.5 31-47 27.5 6-107
ICU mortality, % (N) 25%(1) 0%(0)
Hospital mortality, % (N) 25%(1) 0%(0)
Clinical data of the patients during their hospitalisation in the ECMO-centre
and the outcome.
LOS: length of stay; LOS-T: total length of stay (peripheral hospital+ecmo
center); MV: mechanical ventilation.
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longer period than the others: 2.5 vs 1.0 days (median),
the activation was tardier.
It is important to underline the fact that all patients
with ECMO criteria were treated, with no exclusion
from treatment independently from the seriousness of
the case. Several studies noted various complications
during the transfer in ECMO (bleeding, circuit occlu-
sion, breakages in the circuit, etc.) [8-11]; in our experi-
ence, no complications during the transfer on ECMO
occurred. The clinical evaluation and the advanced
treatment by the ECMO team, a multidisciplined equip
with expertise in ARDS and ECMO treatment, allowed
the optimization of the clinical parameters and safe
transport, even over long distances (520 Km), of patients
with extremely serious ARDS.
The evolution of the respiratory insufficiency from
H1N1 to ARDS determined a serious hypoxaemia which
did not respond to treatment with high PEEP or high
FiO2 and was not easily treated with extracorporeal oxy-
genation at low flow. The use of ECMO with medium-
high flow (4-6 l/min) allowed a rapid correction of
blood gases and a speedy transfer to the ECMO centre.
Furthermore, the rapid resolution of the hypoxia
allowed us, from the start, to carry out a protective ven-
tilation strategy during the transport and for the dura-
tion of the hospitalization.
There was no difference in days of mechanical ventila-
tion, ICU-LOS and hospital LOS between the two
groups; one patient in Group A died, none in Group B.
Little has been written on transport while on ECMO
for ARDS in adults [8,10,11]; it has been described only
in one case report for ARDS-related H1N1 [12]. A
recent study described approximately 200 patients with
H1N1-related ARDS treated in 15 Australian and New
Zealand ICUs which used ECMO treatment [13], the
population described is extremely similar to ours in
terms of age, BMI and comorbidity. In this study 30% of
patients (53) against 50% in our centre (7) were treated
with ECMO. This result is explained by the fact that as
our centre is the point of reference for many regions in
central Italy, we treated the more serious patients;
patients who were less serious were treated in the ICU
of their local hospital. The 53 patients treated with
ECMO were similar to our 7 patients in seriousness;
even the duration of the ECMO treatment by mechani-
cal ventilation, ICU-LOS and Hosp. LOS were similar.
In this study the mortality rate was of approximately
15% (23% treated with ECMO, 13% not treated with
ECMO) against our 7%. In our centre we have not regis-
tered deaths of patients on mechanical ventilation. This
difference is partly explained by the fact that the
patients centralized in our ICU were only those poten-
tially curable with ECMO without criteria of exclusion,
the patients with criteria of exclusion from ECMO
treatement stayed at the local hospitals.
The limitation of our study is the impossibility to
compare the mortality rate of patients treated with
ECMO with other reports because the sample was too
small.
Conclusions
The A H1N1 influenza can induce serious ARDS and
non-conventional treatment like ECMO, can be safely
instituted in highly specialized centres. Due to a rapid
progression of respiratory failure, transfer of these
patients to a referral centre on mechanical ventilation is
often infeasible. Therefore the start of ECMO treatment
at the peripheral hospitals and transportation on ECMO
could be a viable option. The creation of an ECMO
team, with experts in the treatment of ARDS, seems a
key aspect for the safe management of these patients,
including when the most advanced technique are not
immediately available.
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